伴高尿酸血症突发性聋患者的临床特征及预后

Clinical Characteristics and Hearing Recovery in Patients with Sudden Sensorineural Hearing Loss with Hyperuricemia

蒋远伟;蔡志福;戴惠婷;林超凡;潘金霞;

1:莆田学院附属医院耳鼻咽喉科

摘要
目的分析伴高尿酸血症突发性聋(突聋)患者的临床特征及听力预后。方法以2016年1月至2020年12月治疗的64例(68耳)伴高尿酸血症突聋患者(高尿酸血症组)为研究对象,选择同期接受治疗的430例(445耳)未合并高尿酸血症的突聋患者(非高尿酸血症组)作为对照组,观察两组患者的临床特征及听力预后;同时根据高尿酸血症的患者是否合并痛风进一步分为痛风组(22例,25耳)和非痛风组(42例,43耳),分析两组患者的特征及听力预后。结果高尿酸血症组患者的初诊听阈值、高血压和糖尿病伴发率、极重度聋和全聋型听阈曲线者所占比例分别为60.22±17.58 dB HL、26.56%、23.43%、36.76%和41.18%,均高于非高尿酸血症组(分别为52.31±13.45 dB HL、14.19%、12.32%、22.70%和27.42%)(均为P<0.05);治疗3个月后,高尿酸血症组痊愈率和总有效率分别为13.23%和58.82%,低于非高尿酸血症组(分别为28.76%和73.71%),而前者的无效率为41.18%,高于后者(26.29%),差异均有统计学意义(均为P<0.05);高尿酸血症组中痛风组的初诊听阈值和全聋型听阈曲线者所占比例分别为68.80±21.30 dB HL和64.00%,均高于非痛风组(分别为53.14±15.63 dB HL和27.91%)(均为P<0.05);治疗后,痛风组中总有效率(36.00%)明显低于非痛风组(67.44%)(P<0.05)。结论突聋伴高尿酸血症尤其合并痛风的患者听力损失程度重,听阈曲线以全聋型为主,治疗效果差。
关键词
突发性聋;高尿酸血症;临床特征;痛风;预后
基金项目(Foundation):
福建省中青年教师教育科研项目(科技类)(JAT200513)资助
作者
蒋远伟;蔡志福;戴惠婷;林超凡;潘金霞;
参考文献

1 刘丹,单春光,张玉波.突发性聋病因学研究进展[J].听力学及言语疾病杂志,2019,27(6):677-680.

2 谭玉芳,贺建桥.伴自身免疫性疾病突发性聋患者的临床特征及预后[J].听力学及言语疾病杂志,2021,29(2):213-216.

3 樊华,曹永华,王忠勋,等.突发性聋患者血脂检测结果分析[J].听力学及言语疾病杂志,2020,28(3):337-338.

4 朱艳香,刘文彬,陈菲,等.甲强龙耳后及鼓室给药治疗伴糖尿病的突发性聋患者的疗效观察[J].听力学及言语疾病杂志,2020,28(4):383-386.

5 段钰瑾,李大红,钟文伟,等.代谢综合征对突发性聋患者听力预后的影响[J].听力学及言语疾病杂志,2020,28(1):46-49.

6 冯文文,崔岱,杨涛.《中国高尿酸血症与痛风诊疗指南(2019)》要点解读[J].临床内科杂志,2020,37(7):528-531.

7 Singh JA,Cleveland JD.Gout and hearing impairment in the elderly:a retrospective cohort study using the US Medicare claims data[J].BMJ Open,2018,8(8):e022854.

8 中华医学会内分泌学分会.中国高尿酸血症与痛风诊疗指南(2019)[J].中华内分泌代谢杂志,2020,36(1):1-13.

9 Neogi T,Jansen TL,Dalbeth N,et al.2015 Gout classification criteria:an American college of rheumatology/european league against rheumatism collaborative initiative[J].Ann Rheum Dis,2015,74(10):1789-1798.

10 黄鸣真.同型半胱氨酸、尿酸与突发性聋关系的研究[J].中国中西医结合耳鼻咽喉科杂志,2010,18(3):153-154.

11 Fasano T,Pertinhez TA,Tribi L,et al.Laboratory assessment of sudden sensorineural hearing loss:a case-control study[J].Laryngoscope,2017,127(10):2375-2381.

12.Ilancioglu M,Ural C,Cobanoglu B,et al.Role of uric acid and other parameters in sudden sensorineural hearing loss[J].Exp Biomed Res,2020,3(2):99-109.

13 Borghi C,Palazzuoli A,Landolfo M,et al.Hyperuricemia:a novel old disorder-relationship and potential mechanisms in heart failure[J].Heart Fail Rev,2020,25(1):43-51.

14 Yang HF,Kao TW,Peng TC,et al.Serum uric acid relation for hearing threshold shift[J].Clin Exp Otorhinolaryngol,2017,10(2):143-147.

15 Braun EM,Karpf EF,Bachna-Rotter S,et al.Conductive hearing loss in association with urate deposits in the middle ear[J].Otol Neurotol,2016,37(8):e252-253.

16 Yücel A,Yücel H,Aydemir F,et al.Determination of hearing levels in gout patients and factors affecting hearing levels such as the dislipidemia,hemoglobin levels and hyperuricemia[J].Am J Otolaryngol,2020,41(5):102565.

17 Song M,Li N,Yao Y,et al.Longitudinal association between serum uric acid levels and multiterritorial atherosclerosis[J].J Cell Mol Med,2019,23(8):4970-4979.